
    
      To determine the safety and tolerability of co-administration of partially HLA antigen
      matched unrelated donor cryopreserved donor lymphocytes (microtransplantation) with
      chemotherapy for patients with high risk acute myeloid leukaemia ineligible or unsuitable for
      high dose chemotherapy and stem cell transplantation.
    
  